A patient-friendly list of symptoms and what to do appears on MedlinePlus: Semaglutide
For those who prefer an alternative to injections, the FDA-approved oral semaglutide pill form, Wegovy, became available in December 2025
Exendin-4 (Ex-4), another GLP-1RA that is homologous to commercially available exenatide, ameliorated IR in primary neurons through insulin receptor substrate-1 (IRS-1), AKT, and glycogen synthase kinase-3 (GSK-3) pathways
Use common language and metaphors to help patients understand the physiological mechanisms behind rebound weight gain
GLP-1 treatment was not associated with an increased risk of thyroid cancer
When these enzymes are blocked, approximately one-third of the fat consumed in a meal cannot be absorbed and is instead excreted in the stool